OUR FOUNDING INVESTORS
ARCH VENTURE PARTNERS
ARCH Venture Partners invests in disruptive innovation in life sciences, physical sciences, and in areas of technology convergence, and manages over $1.4 billion. Over 27 years, ARCH has invested in the founding or Series A round of over 160 companies in biotechnology, energy, and advanced materials, and instrumentation.
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs™, Flagship's innovation foundry which invents and launches transformative companies, and Venture Capital, which finances and develops innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $1.4 billion in capital and has founded more than 35 ventures while investing in another 55. The firm is active in three principal business sectors: therapeutics, health technologies and sustainability.